“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Alprazolam (Alprazolam)

Trade Name : Alprazolam

Mylan Pharmaceuticals Inc.

TABLET

Strength 0.25 mg/1

ALPRAZOLAM Benzodiazepine [EPC],Benzodiazepines [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Alprazolam (Alprazolam) which is also known as Alprazolam and Manufactured by Mylan Pharmaceuticals Inc.. It is available in strength of 0.25 mg/1 per ml. Read more

Alprazolam (Alprazolam) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death (see and ).
  • Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds.
  • The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4-s-triazolo [4,3-u03b1] [1,4] benzodiazepine.
  • The structural formula is represented below:
  • Alprazolam, USP is a white crystalline powder, which is soluble in methanol or ethanol but which has no appreciable solubility in water at physiological pH.
  • Each alprazolam tablet, for oral administration, contains 0.25 mg, 0.5 mg, 1 mg or 2 mg of alprazolam, USP.
  • Inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, docusate sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium benzoate and sodium lauryl sulfate. The 0.5 mg tablets also contain FD&C Yellow No. 6 Aluminum Lake and the 1 mg tablets also contain FD&C Blue No. 2 Aluminum Lake.
  • No data
  • No data
  • No data
  • Alprazolam tablets are contraindicated in patients with known sensitivity to this drug or other benzodiazepines.
  • Alprazolam tablets are contraindicated with ketoconazole and itraconazole, since these medications significantly impair the oxidative metabolism mediated by cytochrome P450 3A (CYP3A) (see and ).
  • No data
  • No data
  • Side effects to alprazolam tablets, if they occur, are generally observed at the beginning of therapy and usually disappear upon continued medication. In the usual patient, the most frequent side effects are likely to be an extension of the pharmacological activity of alprazolam, e.g., drowsiness or light-headedness.
  • The data cited in the two tables below are estimates of untoward clinical event incidence among patients who participated under the following clinical conditions: relatively short duration (i.e., 4 weeks) placebo-controlled clinical studies with dosages up to 4 mg/day of alprazolam tablets (for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety) and short-term (up to 10 weeks) placebo-controlled clinical studies with dosages up to 10 mg/day of alprazolam tablets in patients with panic disorder, with or without agoraphobia.
  • These data cannot be used to predict precisely the incidence of untoward events in the course of usual medical practice where patient characteristics, and other factors often differ from those in clinical trials. These figures cannot be compared with those obtained from other clinical studies involving related drug products and placebo as each group of drug trials are conducted under a different set of conditions.
  • Comparison of the cited figures, however, can provide the prescriber with some basis for estimating the relative contributions of drug and non-drug factors to the untoward event incidence in the population studied. Even this use must be approached cautiously, as a drug may relieve a symptom in one patient but induce it in others. (For example, an anxiolytic drug may relieve dry mouth [a symptom of anxiety] in some subjects but induce it [an untoward event] in others.)
  • Additionally, for anxiety disorders the cited figures can provide the prescriber with an indication as to the frequency with which physician intervention (e.g., increased surveillance, decreased dosage or discontinuation of drug therapy) may be necessary because of the untoward clinical event.
  • In addition to the relatively common (i.e., greater than 1%) untoward events enumerated in the table above, the following adverse events have been reported in association with the use of benzodiazepines: dystonia, irritability, concentration difficulties, anorexia, transient amnesia or memory impairment, loss of coordination, fatigue, seizures, sedation, slurred speech, jaundice, musculoskeletal weakness, pruritus, diplopia, dysarthria, changes in libido, menstrual irregularities, incontinence and urinary retention.
  • In addition to the relatively common (i.e., greater than 1%) untoward events enumerated in the table above, the following adverse events have been reported in association with the use of alprazolam tablets: seizures, hallucinations, depersonalization, taste alterations, diplopia, elevated bilirubin, elevated hepatic enzymes, and jaundice.
  • Panic disorder has been associated with primary and secondary major depressive disorders and increased reports of suicide among untreated patients (see ).
  • No data
  • No data
  • Dosage should be individualized for maximum beneficial effect. While the usual daily dosages given below will meet the needs of most patients, there will be some who require doses greater than 4 mg/day. In such cases, dosage should be increased cautiously to avoid adverse effects.
  • Alprazolam Tablets, USP are available containing 0.25 mg, 0.5 mg, 1 mg or 2 mg of alprazolam, USP.
  • The 0.25 mg tablets are white, round, scored tablets debossed with overon one side of the tablet and scored on the other side. They are available as follows:
  • NDC 0378-4001-05bottles of 500 tablets
  • The 0.5 mg tablets are peach, round, scored tablets debossed with over on one side of the tablet and scored on the other side. They are available as follows:
  • NDC 0378-4003-05bottles of 500 tablets
  • The 1 mg tablets are blue, round, scored tablets debossed with over on one side of the tablet and scored on the other side. They are available as follows:
  • NDC 0378-4005-05bottles of 500 tablets
  • The 2 mg tablets are white, round, scored tablets debossed with over on one side of the tablet and quadrisect scored on the other side. They are available as follows:
  • NDC 0378-4007-01bottles of 100 tablets
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F). [See USP Controlled Room Temperature.]
  • Protect from light.
  • Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
  • PHARMACIST:
  • When rats were treated with alprazolam at 3 mg/kg/day, 10 mg/kg/day, and 30 mg/kg/day (15 to 150 times the maximum recommended human dose) orally for 2 years, a tendency for a dose related increase in the number of cataracts was observed in females and a tendency for a dose related increase in corneal vascularization was observed in males. These lesions did not appear until after 11 months of treatment.
  • This Medication Guide has been approved by the U.S. Food and Drug Administration.
  • Manufactured for:n Morgantown, WV 26505 U.S.A.
  • Manufactured by:n 15 Garnet StreetCarole Park QLD 4300Australia
  • Revised: 1/2020ALP:ALP:R12mmh/ALP:MG:ALP:R2m/ALP:MG:ALP:R2mh2844/3
  • NDC 0378-4001-05
  • AlprazolamTablets, USPu00a0u00a0u00a0u00a0u00a0CIV0.25 mg
  • PHARMACIST: Dispense the MedicationGuide provided separately to each patient.
  • Rx only 500 Tablets
  • Each tablet contains:Alprazolam, USP 0.25 mg
  • Dispense in a tight, light-resistantcontainer as defined in the USPusing a child-resistant closure.
  • Keep container tightly closed.
  • Keep this and all medicationout of the reach of children.
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F).[See USP Controlled RoomTemperature.]
  • Protect from light.
  • Usual Adult Dosage:
  • This container is not intended fordispensing for household use.
  • Medication Guides may be obtainedat or call1-888-839-8993.
  • Manufactured for:n n Morgantown, WV 26505 U.S.A.
  • Made in Australia
  • 2812/2
  • RALP4001B2
  • NDC 0378-4003-05
  • AlprazolamTablets, USPu00a0u00a0u00a0u00a0u00a0CIV0.5 mg
  • PHARMACIST: Dispense the MedicationGuide provided separately to each patient.
  • Rx only 500 Tablets
  • Each tablet contains:Alprazolam, USP 0.5 mg
  • Dispense in a tight, light-resistantcontainer as defined in the USPusing a child-resistant closure.
  • Keep container tightly closed.
  • Keep this and all medicationout of the reach of children.
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F).[See USP Controlled RoomTemperature.]
  • Protect from light.
  • Usual Adult Dosage:
  • This container is not intended fordispensing for household use.
  • Medication Guides may be obtainedat or call1-888-839-8993.
  • Manufactured for:n n Morgantown, WV 26505 U.S.A.
  • Made in Australia
  • 2815/2
  • RALP4003B2
  • NDC 0378-4005-05
  • AlprazolamTablets, USPu00a0u00a0u00a0u00a0u00a0CIV1 mg
  • PHARMACIST: Dispense the MedicationGuide provided separately to each patient.
  • Rx only 500 Tablets
  • Each tablet contains:Alprazolam, USP 1 mg
  • Dispense in a tight, light-resistantcontainer as defined in the USPusing a child-resistant closure.
  • Keep container tightly closed.
  • Keep this and all medicationout of the reach of children.
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F).[See USP Controlled RoomTemperature.]
  • Protect from light.
  • Usual Adult Dosage:
  • This container is not intended fordispensing for household use.
  • Medication Guides may be obtainedat or call1-888-839-8993.
  • Manufactured for:n n Morgantown, WV 26505 U.S.A.
  • Made in Australia
  • 2818/2
  • RALP4005B2
  • NDC 0378-4007-01
  • AlprazolamTablets, USPu00a0u00a0u00a0u00a0u00a0CIV2 mg
  • PHARMACIST: Dispense the accompanyingMedication Guide to each patient.
  • Rx only 100 Tablets
  • Each tablet contains:Alprazolam, USP 2 mg
  • Dispense in a tight, light-resistantcontainer as defined in the USPusing a child-resistant closure.
  • Keep container tightly closed.
  • Keep this and all medicationout of the reach of children.
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F).[See USP Controlled RoomTemperature.]
  • Protect from light.
  • Usual Adult Dosage:
  • Manufactured for:n n Morgantown, WV 26505 U.S.A.
  • Made in Australia
  • 2819/2
  • RALP4007A2

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.